Allan joined ICG in January 2021 and is Managing Director, and Head of Life Sciences, responsible for the Life Science Fund strategy and team at ICG.
Prior to ICG, Allan was Founder and Managing Partner of Bridge Valley Ventures, a successful life science investor, and prior to this was a Partner and Founder of Apposite Capital. Before this Allan was at Abingworth. Formerly a PhD medicinal chemist at Pfizer, he later founded and was CEO of his own life sciences company before it was successfully acquired by Millennium Pharmaceuticals Inc. in 2000 where he became SVP Technology. On his return to the UK in 2003 Allan joined Abingworth to begin his investment career.